Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 21 | 138 | 15 | 19 | 34 |
| Gross Profit | 21 | 138 | 15 | 19 | 34 |
| Operating Expenses | 9,008 | 7,502 | 14,077 | 9,034 | 10,271 |
| Operating Income | -8,987 | -7,364 | -14,062 | -9,015 | -10,237 |
| Other Income | 79 | 4 | -11 | 21 | 14 |
| Pre-tax Income | -8,908 | -7,360 | -14,073 | -8,994 | -10,223 |
| Income Tax | N/A | N/A | -1,621 | N/A | N/A |
| Net Income Continuous | -8,908 | -7,360 | -12,452 | -8,994 | -10,223 |
| Net Income | $-8,908 | $-7,360 | $-12,452 | $-8,994 | $-10,223 |
| EPS Basic Total Ops | -2,088.68 | -6,208.78 | -32,772.43 | -97,426.72 | -124,677.70 |
| EPS Basic Continuous Ops | -2,087.95 | -6,213.11 | -32,740.45 | -79,107.67 | -122,121.30 |
| EPS Diluted Total Ops | -2,088.68 | -6,208.78 | -32,772.43 | -97,426.72 | -124,677.70 |
| EPS Diluted Continuous Ops | -2,087.95 | -6,213.11 | -32,740.45 | -79,107.67 | -122,121.30 |
| EPS Diluted Before Non-Recurring Items | -2,088.68 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,920 | $-7,283 | $-13,992 | $-8,962 | $-10,160 |